Cullinan Associates’s Eastman Chemical EMN Stock Holding History

Cullinan Associates’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-1,900	Closed	-$205K	–	221
2024 Q3	$205K	Buy	+1,900	New	+$190K	0.01%	227
2024 Q1	–	Sell	-2,500	Closed	-$225K	–	248
2023 Q4	$225K	Buy	+2,500	New	+$199K	0.01%	226
2023 Q3	–	Sell	-2,500	Closed	-$209K	–	248
2023 Q2	$209K	Hold	2,500	–	–	0.01%	245
2023 Q1	$211K	Sell	2,500 -415	-14%	-$35.6K	0.01%	237
2022 Q4	$237K	Buy	+2,915	New	+$235K	0.01%	259
2022 Q3	–	Sell	-2,500	Closed	-$224K	–	229
2022 Q2	$224K	Hold	2,500	–	–	0.01%	217
2022 Q1	$280K	Hold	2,500	–	–	0.01%	217
2021 Q4	$302K	Hold	2,500	–	–	0.02%	206
2021 Q3	$252K	Hold	2,500	–	–	0.01%	215
2021 Q2	$292K	Sell	2,500 -32	-1%	-$3.84K	0.02%	202
2021 Q1	$279K	Buy	2,532 +200	+9%	+$21.7K	0.02%	191
2020 Q4	$234K	Buy	+2,332	New	+$216K	0.01%	182

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Cullinan Associates's EMN Position: Q4 2024 in Review

Cullinan Associates sold out of Eastman Chemical (EMN) in Q4 2024, closing a stake of 1,900 shares — an estimated $205K sold.

Cullinan Associates first reported a position in EMN in Q4 2020 and held it in 12 quarters. The position peaked at $302K in Q4 2021. 786 funds tracked by Wall St. Rank hold EMN as of Q4 2024.

Cullinan Associates reported no remaining Eastman Chemical position as of Q4 2024 after selling out during the quarter.
Cullinan Associates sold 1,900 Eastman Chemical shares in Q4 2024, an estimated $205K.
Cullinan Associates first reported a position in Eastman Chemical in Q4 2020 and held it in 12 quarters.
Cullinan Associates's Eastman Chemical position peaked at $302K in Q4 2021.
786 funds tracked by Wall St. Rank held Eastman Chemical as of Q4 2024.

Based on Cullinan Associates's 13F filing for Q4 2024, filed 24 Jan 2025.